Literature DB >> 34244678

Gene editing in patients with amyloidosis.

Gregory B Lim1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34244678     DOI: 10.1038/s41569-021-00599-0

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Ed Gane; Jorg Taubel; Justin Kao; Marianna Fontana; Michael L Maitland; Jessica Seitzer; Daniel O'Connell; Kathryn R Walsh; Kristy Wood; Jonathan Phillips; Yuanxin Xu; Adam Amaral; Adam P Boyd; Jeffrey E Cehelsky; Mark D McKee; Andrew Schiermeier; Olivier Harari; Andrew Murphy; Christos A Kyratsous; Brian Zambrowicz; Randy Soltys; David E Gutstein; John Leonard; Laura Sepp-Lorenzino; David Lebwohl
Journal:  N Engl J Med       Date:  2021-06-26       Impact factor: 91.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.